Deficiency of Rap1-binding protein RAPL causes lymphoproliferative disorders through mislocalization of p27kip1

Koko Katagiri1, Yoshihiro Ueda, Takashi Tomiyama

  • 1Department of Life Science, School of Science and Technology, Kwanseigakuen University, and JST, CREST, 2-1 Gakuen, Sanda, Hyogo 669-1337, Japan.

Immunity
|January 4, 2011
PubMed

Insights

RAPL protein regulates lymphocyte adhesion and proliferation. Its deficiency leads to autoimmune diseases and lymphoma by disrupting cell cycle control via p27(kip1) regulation.

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Biology

Background:

  • RAPL (Ras-associated protein 1) is a known Rap1 effector regulating lymphocyte adhesion.
  • Its role in controlling lymphocyte proliferation and preventing lymphoproliferative disorders remains largely unexplored.

Purpose of the Study:

  • To investigate the novel function of RAPL in regulating lymphocyte proliferation and preventing autoimmunity and lymphoma.
  • To elucidate the molecular mechanism by which RAPL controls cell cycle progression.

Main Methods:

  • Utilized RAPL-deficient mouse models to study lymphocyte behavior and disease development.
  • Analyzed cell cycle progression, Cdk2 kinase activity, and p27(kip1) localization in lymphocytes.
  • Employed site-directed mutagenesis (S10A mutation) in p27(kip1) to assess its functional impact.

Main Results:

  • RAPL-deficient mice developed lupus-like glomerulonephritis and B cell lymphomas.
  • RAPL-deficient lymphocytes exhibited hyperproliferation due to enhanced S phase entry.
  • RAPL suppresses p27(kip1) phosphorylation at S10, promoting its nuclear translocation and inhibiting Cdk2 activity.

Conclusions:

  • RAPL acts as a critical checkpoint for S phase entry, preventing lymphoproliferative disorders.
  • The spatial regulation of p27(kip1) by RAPL is crucial for maintaining immune homeostasis.
  • Targeting the RAPL-p27(kip1) pathway may offer therapeutic strategies for autoimmune diseases and lymphoma.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Rab Proteins01:14

Rab Proteins

Rab proteins constitute the largest family of monomeric GTPases, of which 70 members are present in humans. Rab proteins and their effectors regulate consecutive stages of vesicle transport such as vesicle transport, docking, and fusion to the correct recipient membrane.
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...